Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 2548 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
 

Table of Contents   
LETTER TO THE EDITOR  
Year : 2021  |  Volume : 32  |  Issue : 1  |  Page : 284-285
Coronavirus Disease-2019 in Children with Nephrotic Syndrome


Department of Child Health, Sultan Qaboos University Hospital, Al Khoud, Muscat, Oman

Click here for correspondence address and email

Date of Web Publication16-Jun-2021
 

How to cite this article:
Al Yazidi LS, Al Nabhani DA. Coronavirus Disease-2019 in Children with Nephrotic Syndrome. Saudi J Kidney Dis Transpl 2021;32:284-5

How to cite this URL:
Al Yazidi LS, Al Nabhani DA. Coronavirus Disease-2019 in Children with Nephrotic Syndrome. Saudi J Kidney Dis Transpl [serial online] 2021 [cited 2021 Dec 8];32:284-5. Available from: https://www.sjkdt.org/text.asp?2021/32/1/284/318544


To the Editor,

Coronavirus disease-2019 (COVID-19) started in late December 2019 in Wuhan, China, and declared as a pandemic by the World Health Organization by mid-March due to increase mortality worldwide.[1]

As of 19 August 2020, there has been more than 22 million of confirmed cases, causing more than 780,000 deaths with mortality rate of 3.5%.[2] So far, a total of 83,606 laboratory-confirmed COVID-19 cases reported in Oman with mortality rate of 0.7%.[3] COVID-19 in children generally tends to have a milder disease and better prognosis compared to adults.[4] There is limited literature on the severity of COVID-19 in children with nephrotic syndrome.

In this letter, we report a 10-year-old boy with steroid-sensitive nephrotic syndrome admitted to our hospital with mild COVID-19 which provoked a nephrotic relapse end of July 2020. He presented with 5-day history of rhinorrhea, facial edema, abdominal distension, and proteinuria. Earlier on, he got exposed to a family member with confirmed COVID-19. He was initially managed at home with prednisone 60 mg/m2 daily, but his edema worsened requiring admission for albumin infusions. He was admitted for 48 h after which he was discharge home on oral prednisolone of 60 mg/m2 daily. He had a mild course at home, and once the proteinuria had resolved, the prednisone was tapered down to 40 mg/m2 given on alternate days. To the best of our knowledge, this is the first reported case of COVID-19 among Omani children with nephrotic syndrome.

A global survey conducted by the European Rare Kidney Disease Reference Network early in the start of the pandemic reported 18 children with kidney diseases on immunosuppressive medications who all have mild COVID-19 of whom three have nephrotic syndrome. Eleven children required hospitalization but none required intensive care.[5] Angeletti et al reported that none of the 159 children with nephrotic syndrome receiving anti-CD20 in combination of other immunosuppressive medications they followed up in Italy during the peak of the pandemic developed COVID-19 including the children who got exposed to confirmed cases of COVID-19 at home. Melgosa et al reported 16 children with chronic kidney disease who all got mild COVID-19 without significant complications from Spain. Four children with nephrotic syndrome; two were asymptomatic and they were continued on maintenance immunosuppression without any modifications and two children had COVID-19 provoked a nephrotic relapse. They were managed with prednisolone without any complications.[2] From these findings, it seems that COVID-19 does not cause severe disease in children with nephrotic syndrome and children on chronic immunosuppressive medication may not be at increased risk of getting COVID-19 provided; they follow optimal preventive measures. They suggested keeping the same immunosuppressive regimen for children with nephrotic syndrome even after exposure to confirmed cases.[6]

From our experience in Oman over the last five months, COVID-19 has not been a major problem among children with nephrotic syndrome. The available literature suggests that children with nephrotic syndrome tend to have mild course of COVID-19. It is recommended to treat relapses of nephrotic syndrome promptly with the standard dose of prednisolone to avoid complications associated with anasarca and bacterial infections.

Conflict of interest: None declared.



 
   References Top

1.
WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19: 11th March 2020. Published March 11, 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—20-march-2020. [Last accessed on 20 Aug 20].  Back to cited text no. 1
    
2.
Melgosa M, Madrid A, Alvárez O, et al. SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. Pediatr Nephrol 2020;35:1521-4.  Back to cited text no. 2
    
3.
World Health Organization. Coronavirus (COVID-19). Oman. Available from: https://who.sprinklr.com/region/emro/country/om. [Last accessed on 20 Aug 20].  Back to cited text no. 3
    
4.
Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020;109: 1088-95.  Back to cited text no. 4
    
5.
Marlais M, Wlodkowski T, Vivarelli M, et al. The severity of COVID-19 in children on immunosuppressive medication. Lancet Child Adolesc Health 2020;4:e17-8.  Back to cited text no. 5
    
6.
Angeletti A, Drovandi S, Sanguineri F, et al. COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression. Clin J Am Soc Nephrol 2020;15:1494-5.  Back to cited text no. 6
    

Top
Correspondence Address:
Laila S Al Yazidi
Department of Child Health, Sultan Qaboos University Hospital, Al Khoud, Muscat
Oman
Login to access the Email id


DOI: 10.4103/1319-2442.318544

PMID: 34145151

Rights and Permissions



This article has been cited by
1 COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area
William Morello, Federica Alessandra Vianello, Emanuele Proverbio, Licia Peruzzi, Andrea Pasini, Giovanni Montini
Pediatric Nephrology. 2021;
[Pubmed] | [DOI]



 

Top
   
 
 
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  
 


 
    References
 

 Article Access Statistics
    Viewed616    
    Printed8    
    Emailed0    
    PDF Downloaded99    
    Comments [Add]    
    Cited by others 1    

Recommend this journal